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270a Monday, March 7, 2011gating kinetics, with the CTD of GluN2A receptors playing a major role in
maintaining high open probabilities.
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Role of Salt Bridges within the Ligand Binding Domains of NMDA Recep-
tors During Receptor Activation
Meaghan Paganelli, Gabriela K. Popescu.
Glutamatergic synaptic transmission mediated by the N-methyl-D-aspartate
(NMDA) receptor plays a fundamental role in numerous central nervous system
processes, but how the receptor becomes active is insufficiently understood.
Structural studies of isolated ligand-binding domains (LBDs) revealed that ag-
onists bind between two flexible lobes (D1 and D2) and by causing the lobes to
move closer together initiate the activation reaction. In many cases, the efficacy
of the agonist correlates with how narrow the cleft becomes and/or how stable
the closed-cleft conformation is. In NMDA receptors, full-agonists induce
cleft-closure and the formation of new stabilizing electrostatic interactions
across the lobes of soluble LBDs. However, how these interactions contribute
to the kinetics of NMDA receptors is not known. To evaluate the roles of pu-
tative cross-cleft interactions to the activation mechanism of intact receptors,
we eliminated these salt bridges in individual subunits and quantified their ef-
fect on gating by kinetic analyses of single channel traces. We were surprised to
find that: receptors containing GluN1(K483A) and GluN2A(K487A) had activ-
ities that were ~10% higher than wild-type controls; receptors containing
GluN1(K483M) had wild-type activity; and those containing GluN2(N687L)
had activities that were ~30% lower than controls. These results suggest that
at these positions, residue-size as well as the ability to form cross-cleft interac-
tions affect the gating process. They also reveal subtle distinctions between
how residues in the GluN1 and GluN2A LBDs contribute to gating.
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Constraining Gating Actions of Specific Subunits During NMDA Receptor
Activation
Iehab Talukder, Rashek Kazi, Lonnie P. Wollmuth.
NMDA receptor activation gating initiates at its extracellular ligand-binding
domain (LBD) and culminates in opening of the associated ion channel. Kinet-
ically, this gating transition occurs through sequential intermediaries with at
minimum three pre-open and two open states. The overall gating transition oc-
curs in a concerted manner only after each subunit has bound its respective li-
gand. Functional NMDA receptors, however, are obligate heterotetramers,
typically composed of two glycine-binding GluN1 and two glutamate-binding
GluN2 subunits. To study subunit-specific contributions to gating kinetics, we
constrained relative movements of the M3/M3-S2 central channel gating axis
through intra-subunit disulfide cross-linking of partner positions in the M3-
S2 and S2-M4 LBD-ion channel linkers, GluN1(C,C) and GluN2A(C,C). Anal-
ysis of single-channel recordings revealed the cross-linked receptors to be in-
efficient in activation gating, with a significantly lower Po [mean SEM; 0.02
5 0.005 for GluN1(C,C)-GluN2A vs. 0.61 5 0.05 for GluN1-GluN2A].
This 30-fold reduction in Po is manifested by both a 6-fold decrease in mean
open duration (1.3 5 0.2 vs. 8.3 5 0.7 ms) and an 18-fold increase in mean
closed duration (94 5 20 vs. 5.1 5 0.7 ms). The cross-linked receptors un-
dergo only flickery openings to a short-lived open state (tO1, 0.25 5 0.05
vs. 0.125 0.01 ms) and virtually do not visit the main long-lived (~ 8.7 ms)
open state. Instead, cross-linked receptor activity is locked into two long-lived
pre-open states (tC3, 38 5 9 vs. 4.2 5 0.4; tC4, 208 5 45 vs. 52 5 3 ms).
Thus, GluN1 subunit-specific constraint of its M3/M3-S2 gating axis most
strongly affects the kinetic end states of activation gating, with minimal, if
any, perturbation of the intermediate states. These results support a tightly cou-
pled LBD to ion channel gating machinery in the NMDA receptor.
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Atp4- Activates P2x Receptors
Mufeng Li, Shai D. Silberberg, Kenton J. Swartz.
P2X receptors are non-selective cation channels that are involved in many im-
portant physiological processes, including neurotransmission and inflamma-
tion. Extracellular ATP released from synaptic vesicles or damaged tissues
has been demonstrated to be the ligand for activating P2X receptors. However,
it is not clear if ATP activates P2X receptors in its free anionic form as ATP4-,
or in complex with divalent cations such as magnesium (MgATP)2-. Here we
examined if ATP can open the channels in the absence of divalent cations,
and tested the effects of different concentrations of Mg2þ on the dose response
curve for channel activation by ATP. The results show that all seven subtypes
of P2X receptors can be activated by ATP4-, and on all but one subtype of P2X
receptor, Mg2þ has a modulatory effect. In the one exception, we found that
Mg2þ competes with P2X receptors for ATP4-, suggesting that (MgATP)2- is
not the agonist. In summary, our results suggest that free ATP, but not magne-
sium bound ATP, is the ligand for opening P2X receptors.1473-Pos Board B383
Application of the Cytopatch Instrument for Compound Screening of
Ligand-Gated ion Channels
Thomas Knott, Gesa Rascher-Eggstein, Olaf Scheel.
Ligand-gated ion channels are in the focus of the pharmaceutical research as
important drug targets, like the family of GABA receptors, 5-HT receptors,
acetylcholine receptors (AChR), P2X receptors or TRP channels. The method
of choice to screen for ligand-gated ion channel modulators is the automated
patch clamp technique but a combination of high data quality and high through-
put is required to carry out successful and efficient compound screens.
Thus, patch clamp screening of ligand-gated ion channels demands of flexible
application schemes and a very rapid ligand application below 50 ms. Further-
more, a fast and complete wash out of agonists is a premise for a good data
quality, because desensitization of some ligand-gated ion channels can lead
to failures in current quantification due to low leftovers of the ligands. This
specification is a big challenge for automated patch clamp instruments, as
very fast movements of microfluidics must be controlled precisely whilst rup-
turing of the cell must be excluded.
Here, we show that the CytoPatch Instrument with its unique application tech-
nique is well suited for the investigation of ligand-gated ion channels: The appli-
cationof agonists is accomplishedwithin 25ms, as shown for the nicotinicAChR
in TE672 cells. Furthermore the investigation of the purinergic P2RX7 receptor
is presented. Desensitization or rundown has not been detected. Offering a fast
and flexible perfusion, the instrument allows to investigate agonistic and antag-
onistic modulation of ligand-gated channels with a data quality similar to that of
the manual patch clamp. With its modular assembly throughput is individually
scalable by the numbers of CytoPatch modules within a screening facility.
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P2X7 Receptor-Mediated Currents in Rat Hypothalamic Neurohypophy-
sial System Terminals
Adolfo E. Cuadra, Thomas K. Knott, Edward Custer, Jose´ R. Lemos.
ATP facilitates the process of secretion by stimulation of purinergic P2X recep-
tors (P2XR) in secretory cells and neurons. While the expression and function
of the P2X(7)R-subtype in neurons is controversial, studies show that P2x(7)R
mRNA is present in the brain, including in the hypothalamic neurohypophysial
system (HNS). Our laboratory has reported that HNS arginine-vasopressin
(AVP) terminals exhibit P2x(7)R immunoreactivity (IR) along with other
P2xR subtypes, while oxytocin (OT) terminals display only P2X(7) IR. There-
fore, our objective was to characterize P2x7R function in isolated HNS termi-
nals from rat brain.
The P2x(7)R is distinguished from other P2XR types by low sensitivity to ATP
(EC50>100 mM) and potent inhibition by Brilliant Blue-G (BBG;
IC50<<mM). In voltage clamp experiments OT terminals showed negligible
response to 10 mM ATP, an effective dose for other P2XR. In turn, 300 mM
ATP induced a rapidly-activated, slowly-inactivating current that was revers-
ibly inhibited by 300 nM BBG. These results are consistent with P2x(7)R func-
tion in OT terminals. We have reported that AVP containing terminals
generated maximal current with 100 mM ATP that was blocked by the P2XR
inhibitor PPADS (10 mM). Dose-response experiments performed using higher
ATP doses (up to 1 mM) revealed increasing current amplitudes with 300 mM
and 1 mM application in AVP terminals. Subsequent treatment with PPADS
nearly abolished current stimulated at 10 mM ATP. However, 1 mM ATP ap-
plication revealed a resistant current-component of approximately 20 percent
of total. This component was reversibly inhibited by 300 nM BBG. The pres-
ence of low ATP-sensitive currents, which is inhibited by BBG, is consistent
with P2x(7)R function in OT and AVP containing terminals. To our knowledge
this is the first direct evidence of P2x(7)R function shown in neuronal termi-
nals. (supported by NIH grant NS29470 to JRL)
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Validation of Screening Assays for Ligand Gated ion Channels on Qpatch
HTX
Søren Friis, Mats H. Holmqvist, Lars D. Løjkner, M. Knirke Jensen,
Morten Sunesen.
QPatch HTX has the highest throughput in the QPatch series. With signature
features such as unattended operations, eight pipettes and the integrated micro-
fluidic glass flow channels of the QPlates, the QPatch HTXis well suited for
testing ligand gated ion channels. The recent advent of a QPlate with 10 patch
holes per measurement site, instead of the classical single patch holehas mini-
mized problems with low expression or problems with stability of the recodings
over time. The success rate of recording on QPatch HTX is therefore approach-
ing 100% for a number of different applications. We have previously shown
that compound profiling on a wide variety of ligand-gated ion channels is cer-
tainly possible on the QPatch. With the increased stability and success rates of
